OTC Markets OTCPK - Delayed Quote USD

CBD Life Sciences Inc. (CBDL)

Compare
0.0004 -0.0002 (-33.33%)
At close: December 11 at 3:59:05 PM EST
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for CBDL

Recent News: CBDL

View More
CBD Life Sciences Inc. (CBDL) Looking to Acquire a Cannabis Growth License in North Las Vegas

CBD Life Sciences Inc. (CBDL) Looking to Acquire a Cannabis Growth License in North Las Vegas
ACCESSWIRE 23 hours ago
CBD Life Sciences, Inc. (CBDL) Reports Stunning 622% Revenue Growth From June to November 2024

CBD Life Sciences, Inc. (CBDL) Reports Stunning 622% Revenue Growth From June to November 2024
ACCESSWIRE 6 days ago
CBD Life Sciences Inc. (CBDL) Announces New Delta-8 100MG Gummies Designed to Support Individuals Living With Alzheimer’s

CBD Life Sciences Inc. (CBDL) Announces New Delta-8 100MG Gummies Designed to Support Individuals Living With Alzheimer’s
ACCESSWIRE 8 days ago
CBD Life Sciences Inc. (CBDL) Closes on LOI for Potential $8 Million Revenue Cannabis Dispensary

CBD Life Sciences Inc. (CBDL) Closes on LOI for Potential $8 Million Revenue Cannabis Dispensary
ACCESSWIRE 22 days ago
CBD Life Sciences Inc. (CBDL) Applies for Beer & Liquor License to Sell CBD Wine

CBD Life Sciences Inc. (CBDL) Applies for Beer & Liquor License to Sell CBD Wine
ACCESSWIRE 28 days ago
CBD Life Sciences, Inc. (CBDL) Positioned for Unmatched Growth as Trump Welcomes Weed Legalization and Federal Rescheduling

CBD Life Sciences, Inc. (CBDL) Positioned for Unmatched Growth as Trump Welcomes Weed Legalization and Federal Rescheduling
ACCESSWIRE last month
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping Into a Booming $20 Billion Market

CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping Into a Booming $20 Billion Market
ACCESSWIRE last month
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High-Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value

CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High-Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value
ACCESSWIRE last month
CBD Life Sciences Inc. (CBDL) Positioned for Significant Growth Amid Nationwide Marijuana Legalization Push

CBD Life Sciences Inc. (CBDL) Positioned for Significant Growth Amid Nationwide Marijuana Legalization Push
GlobeNewswire last month
CBD Life Sciences, Inc. (CBDL) Secures Breakthrough Walmart Marketplace Approval for 3000MG Pain Relief Cream, Setting the Stage for Unprecedented Growth

CBD Life Sciences, Inc. (CBDL) Secures Breakthrough Walmart Marketplace Approval for 3000MG Pain Relief Cream, Setting the Stage for Unprecedented Growth
ACCESSWIRE last month
CBD Life Sciences, Inc. (CBDL) Announces a Staggering 1744.00% Revenue Growth as Innovation and Strategic Expansion Drive Market Dominance

CBD Life Sciences, Inc. (CBDL) Announces a Staggering 1744.00% Revenue Growth as Innovation and Strategic Expansion Drive Market Dominance
ACCESSWIRE last month
View More

Related Tickers

CBDD CBD of Denver Inc.
0.0004
-12.50%
 
CBGL Cannabis Global, Inc.
0.0002
+100.00%
 
BLEG Branded Legacy Inc
0.0004
-20.00%
 
GCAN The Greater Cannabis Company, Inc.
0.0004
0.00%
 
MCOA Marijuana Company of America, Inc.
0.0000
0.00%
 
VDRM ViaDerma, Inc.
0.0090
-2.17%
 
IGPK Integrated Cannabis Solutions, Inc.
0.0049
+4.26%
 
GRPS Gold River Productions, Inc.
0.0003
0.00%
 
ERBB American Green, Inc.
0.0007
0.00%
 
KGKG NuVibe, Inc.
0.0002
-25.00%